EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine

被引：0
|
作者：
N Mas-Sala
M Quintana
J Alvarez-Sabin
P Pozo-Rosich
机构：
[1] Hospital Universitari Vall d'Hebron,Neurology
来源：
The Journal of Headache and Pain | 2014年 / 15卷
关键词：
Migraine; Early Response; Chronic Migraine; Headache Frequency; Episodic Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictors of early response to onabotulinumtoxin type a in chronic migraine
    Mas-Sala, N.
    Quintana, M.
    Alvarez-Sabin, J.
    Pozo-Rosich, P.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [2] EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
    E Cernuda-Morollón
    P Martínez-Camblor
    E Serrano-Pertierra
    D Larrosa
    C Ramón
    J Pascual
    The Journal of Headache and Pain, 2014, 15
  • [3] Predictors of response to onabotulinumtoxin A in chronic migraine
    Barbanti, P.
    Egeo, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (03) : E40 - E40
  • [4] CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
    Cernuda-Morollon, Eva
    Martinez-Camblor, Pablo
    Ramon, Cesar
    Larrosa, Davinia
    Serrano-Pertierra, Esther
    Pascual, Julio
    HEADACHE, 2014, 54 (06): : 987 - 995
  • [5] CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
    Cernuda-Morollon, E.
    Martinez-Camblor, P.
    Serrano-Pertierra, E.
    Larrosa, D.
    Ramon, C.
    Pascual, J.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [6] Molecular markers as predictors of efficacy of onabotulinumtoxin type a treatment in chronic migraine
    Dominguez, C.
    Sobrino, T.
    Rodriguez-Osorio, X.
    Lopez, A.
    Campos, F.
    Martinez Vazquez, F.
    Castillo, J.
    Leira, R.
    CEPHALALGIA, 2015, 35 : 249 - 250
  • [7] Unilateral pain and shorter duration of chronic migraine are significant predictors of response to onabotulinumtoxin A
    Dominguez, C.
    Pozo-Rosich, P.
    Leira, Y.
    Leira, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (04) : E48 - E48
  • [8] EHMTI-0270. Experience with onabotulinumtoxin type a in high-frequency episodic migraine
    P Pozo-Rosich
    M Quintana
    J Alvarez-Sabin
    N Mas Sala
    The Journal of Headache and Pain, 2014, 15
  • [9] DOSE-RESPONSE ANALYSIS OF ONABOTULINUMTOXIN A IN CHRONIC MIGRAINE
    Trimboli, M.
    Andreou, A. P.
    Murphy, M.
    Al-Kaisy, A.
    Lambru, G.
    CEPHALALGIA, 2016, 36 : 46 - 46
  • [10] CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
    Dominguez, Clara
    Vieites-Prado, Alba
    Perez-Mato, Maria
    Sobrino, Tomas
    Rodriguez-Osorio, Xiana
    Lopez, Ana
    Campos, Francisco
    Martinez, Francisco
    Castillo, Jose
    Leira, Rogelio
    HEADACHE, 2018, 58 (01): : 78 - 87
12345